Boccia Delia, Guthmann Jean-Paul, Klovstad Hilde, Hamid Nuha, Tatay Mercedes, Ciglenecki Iza, Nizou Jacques-Yves, Nicand Elisabeth, Guerin Philippe Jean
European Programme for Intervention Epidemiology Training, Stockholm, Sweden.
Clin Infect Dis. 2006 Jun 15;42(12):1679-84. doi: 10.1086/504322. Epub 2006 May 12.
Hepatitis E virus (HEV) causes acute onset of jaundice and a high case-fatality ratio in pregnant women. We provide a clinical description of hospitalized case patients and assess the specific impact on pregnant women during a large epidemic of HEV infection in a displaced population in Mornay camp (78,800 inhabitants), western Darfur, Sudan.
We reviewed hospital records. A sample of 20 clinical cases underwent laboratory confirmation. These patients were tested for immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody to HEV (serum) and for amplification of the HEV genome (serum and stool). We performed a cross-sectional survey in the community to determine the attack rate and case-fatality ratio in pregnant women.
Over 6 months, 253 HEV cases were recorded at the hospital, of which 61 (24.1%) were in pregnant women. A total of 72 cases (39.1% of those for whom clinical records were available) had a diagnosis of hepatic encephalopathy. Of the 45 who died (case-fatality ratio, 17.8%), 19 were pregnant women (specific case-fatality ratio, 31.1%). Acute hepatitis E was confirmed in 95% (19/20) of cases sampled; 18 case-patients were positive for IgG (optical density ratio > or =3), for IgM (optical density ratio >2 ), or for both, whereas 1 was negative for IgG and IgM but positive for HEV RNA in serum. The survey identified 220 jaundiced women among the 1133 pregnant women recorded over 3 months (attack rate, 19.4%). A total of 18 deaths were recorded among these jaundiced pregnant women (specific case-fatality ratio, 8.2%).
This large epidemic of HEV infection illustrates the dramatic impact of this disease on pregnant women. Timely interventions and a vaccine are urgently needed to prevent mortality in this special group.
戊型肝炎病毒(HEV)可导致急性黄疸发作,且在孕妇中的病死率很高。我们对住院病例患者进行了临床描述,并评估了在苏丹西达尔富尔州莫尔奈营地(78,800居民)流离失所人群中发生的戊型肝炎病毒大规模感染疫情期间,该病毒对孕妇的具体影响。
我们查阅了医院记录。对20例临床病例样本进行了实验室确诊。对这些患者检测了戊型肝炎病毒免疫球蛋白G(IgG)和免疫球蛋白M(IgM)抗体(血清)以及戊型肝炎病毒基因组扩增情况(血清和粪便)。我们在社区进行了横断面调查,以确定孕妇中的发病率和病死率。
在6个月的时间里,医院记录了253例戊型肝炎病例,其中61例(24.1%)为孕妇。共有72例(占可获取临床记录病例的39.1%)被诊断为肝性脑病。在死亡的45例患者中(病死率为17.8%),19例为孕妇(特定病死率为31.1%)。在抽样的病例中,95%(19/20)确诊为急性戊型肝炎;18例病例患者的IgG(光密度比值≥3)、IgM(光密度比值>2)或两者均呈阳性,而1例患者的IgG和IgM均为阴性,但血清中的戊型肝炎病毒RNA呈阳性。该调查在3个月内记录的1133名孕妇中发现了220例黄疸妇女(发病率为19.4%)。在这些黄疸孕妇中,共记录到18例死亡(特定病死率为8.2%)。
这次戊型肝炎病毒大规模感染疫情表明了该疾病对孕妇的巨大影响。迫切需要及时采取干预措施和研发疫苗,以预防这一特殊群体的死亡。